Zhejiang Jingxin Pharmachutical Co.,ltd.

The company was founded in 1990 and is a listed pharmaceutical company integrating R&D, production and sales. The company follows the business policy of “strengthening the main pharmaceutical industry and developing medical devices”, adheres to the core corporate values of “pragmatism, innovation, inclusiveness and win-win”, takes “careful protection of health” as its mission, and is committed to becoming a leader in the mental, neurological, cardiovascular and cerebrovascular fields in China. The company is mainly engaged in R&D, production and sales of chemical preparations, traditional Chinese medicines, biological agents, chemical raw materials, and medical devices. The company's main products are rehabilitation solutions, Bacillus lichens active bacteria capsules, simvastatin tablets, robustatin calcium tablets, pivastatin calcium dispersible tablets, sertraline hydrochloride tablets, levetiracetam tablets, praxol tablets, carbalatin bitartrate capsules, didacinib capsules and other preparations, as well as quinolones, statins, neuropsychiatric raw materials and medical display products. The company has been on the “China Chemical and Pharmaceutical Industry Excellent Pharmaceutical Export Enterprise Brand”, “China's Top 100 Pharmaceutical Industry” and “China's Top 100 Chemical and Pharmaceutical Companies List” for many years. Patented technology related to product processes has won the Chinese Patent Gold Award, the first prize of the Zhejiang Intellectual Property Award, and the first prize of the Zhejiang Science and Technology Progress Award.